Company Analysis

BioAtla, Inc. (BCAB)

OTC: BCAB · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2020
Grade4.9
◀ Past 4.8● Present 4.0▶ Future 5.7
5 est.

Who runs BioAtla, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Short Jay M Phd
Chief Executive Officer. First filing Dec 2020, latest Sep 2, 2026, 10 filings in all.
Officers reporting now
4
of 4 people with a filing in the last fifteen months
Directors reporting now
0
14 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Short Jay M PhdChief Executive OfficerDec 2020Sep 2, 2026none
Vasquez ChristianChief Financial OfficerDec 2020Sep 2, 2026none
Sievers EricChief Medical OfficerDec 2020Sep 2, 2026none
Waldron Richard AFormer Chief Financial OfficerDec 2020Mar 2, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BCAB · research, not advice